“We are delighted to welcome Taiho Pharma as a member of Vivli and to be able to partner with them to manage requests received for their individual patient-level data from completed clinical trials,” said Rebecca Li, Vivli Executive Director.

Taiho Pharma is an R&D-driven specialty pharma focusing on the three fields of oncology, allergies and immunology, and urology. As a company, they are determined to deliver new drugs that maximize health benefits to patients around the world.

For more information about how Taiho shares data on Vivli, please visit their member page. For additional information about Membership in Vivli, learn more here.